Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Cognigenics is the developer of mental healthcare drugs and therapies intended to transform mental health in the genetic age. The company specializes in cognitive neuro-engineering for the genetic engineering of desirable cognitive traits, such as mindfulness, relaxation, and mental acuity, enabling patients to offset cognitive deficits in people suffering from mental health issues such as stress, anxiety, and depression.

List your booth number for exhibitions, ask us